Sign in
4

Changes in Ownership

INTERPACE BIOSCIENCES, INC. Filed Acc 0001493152-20-001534

Options or other derivatives

  • Chief Financial Officer acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Knechtel Fred S. · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-01-29 Grant or award : show line 1 in the form Stock Option (right to buy) +60,000 60,000 D
Loading xslF345X03/ownership.xml…